§ 601.9. Licenses; reissuance.
160 words·~1 min read·
/us/cfr/t21/s§ 601.9·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
(a)Compliance with requirements. A biologics license, previously suspended or revoked, may be reissued or reinstated upon a showing of compliance with requirements and upon such inspection and examination as may be considered necessary by the Director, Center for Biologics Evaluation and Research or the Director, Center for Drug Evaluation and Research.
(b)Exclusion of noncomplying location. A biologics license, excluding a location or locations that fail to comply with the requirements in this chapter, may be issued without further application and concurrently with the suspension or revocation of the license for noncompliance at the excluded location or locations.
(c)Exclusion of noncomplying product(s). In the case of multiple products included under a single biologics license application, a biologics license may be issued, excluding the noncompliant product(s), without further application and concurrently with the suspension or revocation of the biologics license for a noncompliant product(s). [64 FR 56451, Oct. 20, 1999, as amended at 70 FR 14983, Mar. 24, 2005]
Connections1 cite this
Cited by 1 section
register
Citation graph
cites case law
§ 601.9
Licenses; reissuance.
Fed. Reg.×1
Cites 0Cited by 1 across 1 source